Kidney failure risk equation 計算機
用於計算慢性腎臟病患者進展為末期腎衰竭的風險。
(估算2年與5年內需要透析的機率)
*若輸入所有選填項,將使用8-variable equation;
若有未填項目,則使用4-variable equation。
5年風險 3~5%:建議轉介腎臟科醫師
2年風險 ≥10%:建議多專科聯合治療
2年風險 ≥40%:準備腎臟替代治療(腎移植或動靜脈瘻)
Reference :
Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011
Tangri N, Grams ME, Levey AS et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016
什麼是 Kidney Failure Risk 公式?
Kidney failure risk equation 最初由加拿大研究團隊開發,研究對象為慢性腎臟病(CKD)第3~5期患者,並已在全球超過30個國家、70萬名患者中驗證。該公式使用4或8個變數,用以預測2年與5年內需透析或腎臟移植的風險。此外,針對非北美地區的族群,亦加入了校正係數。
KDIGO 2024 CKD 指南建議使用經外部驗證的風險公式,以評估腎衰竭的絕對風險。
- 若5年 kidney failure risk 為3~5%:建議轉介腎臟科醫師。
- 若2年 kidney failure risk 超過40%:應考慮進行腎臟替代治療的準備,例如建立透析血管通路或腎臟移植。

上述計算器中使用的公式 (Kidney failure risk equation) :
4-variable equation, Patient 2-year risk, non-North America
1 – 0.9832 ^ exp (-0.2201 × (age/10 – 7.036) + 0.2467 × (male – 0.5642) – 0.5567 × (eGFR/5 – 7.222) + 0.4510 × (logACR – 5.137))
4-variable equation, Patient 5-year risk, non-North America
1 – 0.9365 ^ exp (-0.2201 × (age/10 – 7.036) + 0.2467 × (male – 0.5642) – 0.5567 × (eGFR/5 – 7.222) + 0.4510 × (logACR – 5.137))
4-variable equation, Patient 2-year risk, North America
1 – 0.9750 ^ exp (-0.2201 × (age/10 – 7.036) + 0.2467 × (male – 0.5642) – 0.5567 × (eGFR/5 – 7.222) + 0.4510 × (logACR – 5.137))
4-variable equation, Patient 5-year risk, North America
1 – 0.9240 ^ exp (-0.2201 × (age/10 – 7.036) + 0.2467 × (male – 0.5642) – 0.5567 × (eGFR/5 – 7.222) + 0.4510 × (logACR – 5.137))
8-variable equation, Patient 2-year risk, non-North America
1 – 0.9827 ^ exp (-0.1992 × (age/10 – 7.036) + 0.1602 × (male – 0.5642) – 0.4919 × (eGFR/5 – 7.222) + 0.3364 × (logACR – 5.137) – 0.3441 × (albumin – 3.997) + 0.2604 × (phosphorous – 3.916) – 0.07354 × (bicarbonate – 25.57) – 0.2228 × (calcium – 9.355))
8-variable equation, Patient 5-year risk, non-North America
1 – 0.9245 ^ exp (-0.1992 × (age/10 – 7.036) + 0.1602 × (male – 0.5642) – 0.4919 × (eGFR/5 – 7.222) + 0.3364 × (logACR – 5.137) – 0.3441 × (albumin – 3.997) + 0.2604 × (phosphorous – 3.916) – 0.07354 × (bicarbonate – 25.57) – 0.2228 × (calcium – 9.355))
8-variable equation, Patient 2-year risk, North America
1 – 0.9780 ^ exp (-0.1992 × (age/10 – 7.036) + 0.1602 × (male – 0.5642) – 0.4919 × (eGFR/5 – 7.222) + 0.3364 × (logACR – 5.137) – 0.3441 × (albumin – 3.997) + 0.2604 × (phosphorous – 3.916) – 0.07354 × (bicarbonate – 25.57) – 0.2228 × (calcium – 9.355))
8-variable equation, Patient 5-year risk, North America
1 – 0.9301 ^ exp (-0.1992 × (age/10 – 7.036) + 0.1602 × (male – 0.5642) – 0.4919 × (eGFR/5 – 7.222) + 0.3364 × (logACR – 5.137) – 0.3441 × (albumin – 3.997) + 0.2604 × (phosphorous – 3.916) – 0.07354 × (bicarbonate – 25.57) – 0.2228 × (calcium – 9.355))
Reference :
- Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011
- Tangri N, Grams ME, Levey AS et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016